From studying the human genome to analyzing the way proteins are encoded, or monitoring RNA expression, researchers are rapidly gaining a far richer understanding of the complex genetic and cellular mechanisms that underpin dementia.
New analysis offers most comprehensive roadmap to date for more targeted Alzheimer's research, drug discovery retrieved 24 July 2024 from https://medicalxpress.com/news/2024-07-analysis-comprehensive-roadmap-date-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New study reveals how RNA polymerase opens the transcription bubble in real timeEvery living cell transcribes DNA into RNA. This process begins when an enzyme called RNA polymerase (RNAP) clamps onto DNA.
Read more »
New AI program analyzing speech patterns could predict likelihood of Alzheimer's diseaseTrying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments—interviews, brain imaging, blood and cerebrospinal fluid tests. But, by then, it's probably already too late: memories have started slipping away, long established personality traits have begun subtly shifting.
Read more »
New protein target identified for early Alzheimer's treatmentA class of proteins that regulates cell repair and enhances cell growth-signaling systems could be a promising new target for the treatment of Alzheimer's and other neurodegenerative diseases, according to a new study led by researchers at Penn State.
Read more »
FDA approves new drug to treat Alzheimer's diseaseA new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.
Read more »
A New Alzheimer’s Drug May Be the Most Effective One YetEli Lilly's new drug, donanemab, targets amyloid proteins and slows cognitive decline more than others in its class.
Read more »
Alzheimer's Association publishes final version of its new diagnostic criteria for the diseaseAn international team of medical researchers associated with the nonprofit Alzheimer's Association has published a paper describing the group's final version of their new diagnostic criteria for the disease. Published in Nature Medicine, the paper includes use of plasma biomarkers in diagnosing symptomatic Alzheimer's patients.
Read more »